Cargando…
Surveillance of Human Papilloma Virus Using Reference Laboratory Data for the Purpose of Evaluating Vaccine Impact
Nationwide positivity rates of high-risk human papillomavirus for the United States before and since the introduction of a Human Papillomavirus (HPV) vaccine in 2006 would provide insight into the population impact of HPV vaccination. Data for high-risk HPV testing results from January 1, 2004 to Ju...
Autores principales: | Wilson, Andrew R, Welch, Ryan J., Hashibe, Mia, Greenwood, Jessica, Jackson, Brian, She, Rosemary C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Illinois at Chicago Library
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292532/ https://www.ncbi.nlm.nih.gov/pubmed/25598867 http://dx.doi.org/10.5210/ojphi.v6i3.5593 |
Ejemplares similares
-
Surveillance of Human Papilloma Virus in the United States to Evaluate Vaccine Impact
por: Wilson, Andrew, et al.
Publicado: (2014) -
Factors related to HPV vaccine uptake and 3-dose completion among women in a low vaccination region of the USA: an observational study
por: Wilson, Andrew R., et al.
Publicado: (2016) -
Human Papilloma Virus Vaccination
por: Rosalik, Kendal, et al.
Publicado: (2021) -
Vaccine against human Papilloma Virus
por: Reina, Julio C, et al.
Publicado: (2014) -
Prevalence of human papilloma virus (HPV) genotypes between outpatients males and females referred to seven laboratories in Tehran, Iran
por: Rezaee Azhar, Iman, et al.
Publicado: (2022)